20/09/2024  21:39:07 Chg. - Volume Bid- Demandez à- Capitalisation boursière Dividende Y. Rapport P/E
24.0800USD - 100
Chiffrre d'affaires: 2,408
-Bid taille: - -Ask la taille: - 1.5 Mrd.USD - -

Description de l'entreprise

Genus is a world-leading animal genetics company. It provides farmers with superior genetics that enable them to more efficiently produce higher-quality animal protein, in the form of meat and milk. Genus is the market leader in porcine, dairy and beef genetics and is uniquely positioned as a global player, with a dedicated, multi-species research and development (‘R&D’) function and an international distribution network.
 

Conseil d'administration & Conseil de surveillance

PDG
Jorgen Kokke
Conseil d'administration
Alison Henriksen, Dan Hartley, Jerry Thompson, Angelle Rosata, Dr Elena Rice, Dr Matt Culbertson, Jim Low
Conseil de surveillance
Iain Ferguson, Jorgen Kokke, Alison Henriksen, Lysanne Gray, Lesley Knox, Jason Chin, Dan Hartley, Ralph Heuser
 

Données de l'entreprise

Nom: Genus plc
Adresse: Matrix House, Basing View,UK-Basingstoke RG21 4DZ, Hampshire
Téléphone: +44-1256-347100
Fax: +44-1256-477385
Courriel: cs@genusbreeding.co.uk
Internet: www.genusplc.com/
Industrie: Biotechnology
Secteur: Biotechnology
Sous-secteur: Biotechnology
Fin de l'exercice financier: 30/06
Flotte libre: -
IPO date: -

Relations avec les investisseurs

Nom: Anand Date
Téléphone IR: +44-7815-676-011
IR-Fax: -
E-mail IR: anand.date@genusplc.com

Principaux actionnaires

Autres
 
53.29%
Baillie Gifford
 
7.80%
abrdn
 
6.37%
Wellington Management
 
5.67%
BlackRock
 
5.38%
Vanguard Group
 
5.07%
Devon Equity Management
 
4.41%
Capital Group
 
4.37%
Columbia Threadneedle Investments
 
3.93%
Autres
 
3.71%